Patents by Inventor Mahmoud Abdulhossein POULADI

Mahmoud Abdulhossein POULADI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PRIDOPIDINE FOR THE TREATMENT OF ANXIETY AND DEPRESSION
    Publication number: 20240050423
    Abstract: The invention provides a method of reducing anxiety and/or depression in a subject comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to reduce anxiety and/or depression in a subject.
    Type: Application
    Filed: October 19, 2023
    Publication date: February 15, 2024
    Applicant: Prilenia Neurotherapeutics Ltd.
    Inventors: Michael HAYDEN, Mahmoud Abdulhossein Pouladi
  • USE OF PRIDOPIDINE FOR THE TREATMENT OF FRAGILE X SYNDROME
    Publication number: 20220202798
    Abstract: The invention provides a method of treating a subject afflicted with fragile X syndrome (FXS) or a FXS related disorder, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.
    Type: Application
    Filed: January 31, 2022
    Publication date: June 30, 2022
    Applicants: PRILENIA NEUROTHERAPEUTICS LTD., NATIONAL UNIVERSITY OF SINGAPORE, AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Michael HAYDEN, Mahmoud Abdulhossein POULADI
  • Use of pridopidine for the treatment of fragile X syndrome
    Patent number: 11234973
    Abstract: The invention provides a method of treating a subject afflicted with fragile X syndrome (FXS) or a FXS related disorder, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.
    Type: Grant
    Filed: July 17, 2019
    Date of Patent: February 1, 2022
    Assignees: PRILENIA NEUROTHERAPEUTICS LTD., NATIONAL UNIVERSITY OF SINGAPORE, Agency for Science, Technology and Research
    Inventors: Michael Hayden, Mahmoud Abdulhossein Pouladi
  • USE OF PRIDOPIDINE FOR THE TREATMENT OF ANXIETY AND DEPRESSION
    Publication number: 20210093622
    Abstract: The invention provides a method of reducing anxiety and/or depression in a subject comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to reduce anxiety and/or depression in a subject.
    Type: Application
    Filed: October 20, 2020
    Publication date: April 1, 2021
    Applicant: PRILENIA NEUROTHERAPEUTICS LTD.
    Inventors: Michael HAYDEN, Mahmoud Abdulhossein POULADI
  • USE OF PRIDOPIDINE FOR THE TREATMENT OF ANXIETY AND DEPRESSION
    Publication number: 20200375966
    Abstract: The invention provides a method of reducing anxiety and/or depression in a subject comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to reduce anxiety and/or depression in a subject in the subject.
    Type: Application
    Filed: September 15, 2017
    Publication date: December 3, 2020
    Applicant: PRILENIA THERAPEUTICS DEVELOPMENT LTD
    Inventors: Michael HAYDEN, Mahmoud Abdulhossein POULADI
  • USE OF PRIDOPIDINE FOR THE TREATMENT OF FRAGILE X SYNDROME
    Publication number: 20190336488
    Abstract: The invention provides a method of treating a subject afflicted with fragile X syndrome (FXS) or a FXS related disorder, comprising periodically administering to the subject a pharmaceutical composition comprising an amount of pridopidine effective to treat the subject.
    Type: Application
    Filed: July 17, 2019
    Publication date: November 7, 2019
    Applicants: PRILENIA NEUROTHERAPEUTICS LTD., NATIONAL UNIVERSITY OF SINGAPORE, AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Michael HAYDEN, Mahmoud Abdulhossein POULADI